2018 Annual Cancer Treatment-Related Adverse Events Symposium

Add to Calendar 2018 Annual Cancer Treatment-Related Adverse Events Symposium 10/26/2018 8:30:00 AM 10/27/2018 1:30:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/adverseevents2018 Description: Systemic anticancer therapies including cytotoxic chemotherapies, targeted therapies, and immunotherapies have resulted in improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome... Zuckerman Research Center 417 E 68th St false MM/DD/YYYY

Date & Location

Friday, October 26, 2018, 8:30 AM - Saturday, October 27, 2018, 1:30 PM, Zuckerman Research Center 417 E 68th St

Specialties

Specialties - Allergy and Immunology, Breast Medical Oncology, Cardiology, Dermatology, Emergency Medicine, ENT, Gastroenterology, Gastrointestinal Oncology, Genitourinary Oncology, Geriatric Medicine, Gynecologic Oncology, Head and Neck Oncology, Hematology, Hepatology, Hospice and Palliative Medicine, Infectious Diseases, Integrative Medicine, Internal Medicine, Laboratory Medicine, Leukemia, Lymphoma, Medical Oncology, Nephrology, Neurology, Neuro-Oncology, Nurse Practitioner, Oncology and Hematology, Ophthalmology, Otolaryngology, Pain Medicine, Pathology, Pediatrics, Pharmacology and Medication Management, Physician Assistant, Psychiatry, Radiation Oncology, Rheumatology, Social Work, Solid Tumor Oncology, Urology

Overview

Systemic anticancer therapies including cytotoxic chemotherapies, targeted therapies, and immunotherapies have resulted in improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies. This symposium in endorsed by Multinational Association of Supportive Care in Cancer (MASCC).

The target audience for this symposium includes MDs, PAs, NPs, RNs, Pharmacists, and other professionals involved in the care of cancer patients.

Symposium Highlights

Therapy-related adverse events will affect the majority of patients, resulting in increased cost, inconsistent dosing, and decreased quality of life.
With increased survival and patients living longer on therapy, adverse events affecting quality of life and clinical outcome command attention.
This symposium provides up to date information on adverse event mechanisms and management, from specialists in the most commonly affected organ systems.
Practical strategies to maintain patients’ quality of life and dose intensity will be highlighted for the most frequently occurring events.

Attendees can purchase a copy of Dr Lacouture's book through the following link: Dr. Lacouture's Skin Care Guide for People Living With Cancer. Please note the first 50 attendees will receive a free copy at the symposium. We will notify the first 50 attendees on the day of the course.

NEW! Live Simulcast Available

We are pleased to offer a live simulcast for the 2018 Annual Cancer Treatment-Related Adverse Events Symposium, available for attendees unable to attend this course in person. CME and ABIM MOC credit will still be offered for the live simulcast and active participation is required throughout the course. We do hope you will attend in person but understand that can sometimes be a challenge so we are happy to offer the live simulcast as an option. Register for the live simulcast.

We are pleased to offer a live simulcast option for MSK employees who work outside of the New York City area, including Bergen, Westchester, Basking Ridge, Monmouth, Rockville Centre, Commack and Hauppauge. MSK employees within the New York city area are welcome to attend this course in person at Zuckerman Research Center.

Objectives

Recognize the impact on quality of life, clinical presentation, and grading of treatment-related adverse events in cancer patients
Understand mechanisms and interventions to prevent and treat acute and chronic adverse events in cancer patients
Discuss procedures and clinical tools to assess treatment-related toxicities in cancer patients

Registration

Registration Fees
MDs, DO, PhDs, PAs and NPs	$400
Pharmacists, Nurses and Other Healthcare Providers	$300
Fellows and Residents	$250
Industry Members*	$700

*Industry professionals may attend CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary needs.

30% Discounted Rate for MSK Alumni and MSK Alliance Members -MSK offers a discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact [email protected] for more information or to register.
MSK Staff Registration - Registration is complimentary for MSK staff who wish to attend this course. However, you must complete course registration to attend this course.

After your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.50 Medical Knowledge MOC Points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit

Keywords: